MPTP and rotenone cause dopaminergic neuronal death by increasing DDIT4 promoter lactylation

Jing-Chao Hong1,2, Yu-Shu Yang1,2, Si-Han He1,2

  • 1Institute of Molecular Precision Medicine, Xiangya Hospital, Key Laboratory of Molecular Precision Medicine of Hunan Province, Central South University, Changsha, 410008, China.

Acta Pharmacologica Sinica
|February 13, 2026
PubMed

Insights

Environmental toxicants increase lactate and histone lactylation, damaging dopaminergic neurons in Parkinson's disease. Reducing lactate or inhibiting lactylation protected against neurotoxicity and neuron loss.

Area of Science:

  • Neuroscience
  • Epigenetics
  • Metabolism

Background:

  • Environmental toxicants like MPTP and rotenone are known to induce Parkinsonism.
  • Lactate-driven histone lactylation is implicated in CNS pathology, but its role in Parkinson's disease (PD) pathogenesis is unclear.

Purpose of the Study:

  • To investigate if neurotoxicant-induced histone lactylation contributes to Parkinson's disease pathogenesis.
  • To explore the role of lactate metabolism and histone lactylation in dopaminergic neuron loss.

Main Methods:

  • Exposed SH-SY5Y cells and a mouse model to PD-related neurotoxicants (MPP+, rotenone, MPTP).
  • Utilized RNA-seq and ChIP-seq analyses to identify lactylation targets.
  • Pharmacologically reduced lactate production or inhibited lactylation using sodium dichloroacetate (DCA).

Main Results:

  • Neurotoxicants increased intracellular lactate and histone lactylation by suppressing PDH complex activity.
  • DDIT4 was identified as a lactylation target; its inhibition reduced neurotoxicant-induced cell death and DA neuron loss.
  • DDIT4 was upregulated in a dopaminergic subpopulation vulnerable in PD patients.

Conclusions:

  • Environmental toxicity-induced metabolic alterations drive histone lactylation of the DDIT4 promoter, linking PD stress effectors to epigenetic signals.
  • A lactate-epigenetic axis contributes to environmental toxicant-induced Parkinsonism.
  • Lactate metabolism and histone lactylation are potential therapeutic targets for Parkinson's disease.

Related Concept Videos

The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

4.0K
Increasing Function01:18

Increasing Function

An increasing function exhibits a rise in output values as input values increase. This behavior is depicted graphically as a curve or line that slopes upward from left to right. Such a function satisfies the condition that if x1 < x2, then f(x1) < f(x2), indicating that the function values grow with increasing inputs. This concept is fundamental in understanding growth trends across various domains, such as population dynamics, financial investments, or resource consumption.The...
403
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
7.5K
Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
1.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.6K